Sensus Healthcare First Quarter 2022 Financial Results Feature Revenue Growth of 237%
Diluted EPS from operations of $0.20 compare with $(0.07) in the year-ago quarter Affirms expectations for continued growth in the second quarter and full year profitability Conference call begins at 4:30 p.m. Eastern time today BOCA RATON, Fla., May 05, 2022 — Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in highly effective, […]
Sensus Healthcare to Host First Quarter 2022 Financial Results and Business Update Conference Call on May 5, 2022
BOCA RATON, Fla, April 21, 2022 — Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in highly effective, non-invasive treatments for both oncological and non-oncological conditions, announces that management will hold a conference call on Thursday, May 5, 2022 at 4:30 p.m. Eastern time to discuss the financial results for the first quarter […]
Mata Mata Turtle with Squamous Cell Carcinoma Successfully Treated with Sensus Healthcare’s SRT System by Colorado State University Veterinarian
Joins multiple companion animals and a horse successfully treated with SRT BOCA RATON, Fla. , March 24, 2022 — Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in highly effective, non-invasive, minimally-invasive and cost-effective treatments for oncological and non-oncological conditions, announces that a mata mata turtle has joined the growing list of animal […]
Sensus Healthcare to Present at Two Investment Conferences in March
BOCA RATON, Fla. , March 09, 2022 — Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in highly effective, non-invasive, minimally-invasive and cost-effective treatments for oncological and non-oncological conditions, announces that management will be presenting at the following investment conferences during March: 34th Annual ROTH Conference, March 13-15 at The Ritz-Carlton, Laguna Niguel. […]
Sensus Healthcare Announces Share Repurchase Program
BOCA RATON, Fla, March 09, 2022 — Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in highly effective, non-invasive, minimally-invasive and cost-effective treatments for oncological and non-oncological conditions, announces that its Board of Directors has authorized a program to purchase up to $3,000,000 of shares of its Common Stock. Commenting on this new […]
Sensus Healthcare Sells its Sculptura™ Assets to Empyrean Medical Systems for $15 Million in Cash
Sale permits Sensus to focus on the core dermatology market while providing capital for channel expansion BOCA RATON, Fla., March 02, 2022 — Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in highly effective, non-invasive, minimally-invasive and cost-effective treatments for oncological and non-oncological conditions, announces it has sold its Sculptura™ assets to Empyrean […]
Sensus Healthcare Reports Record Sales and Earnings for the 2021 Fourth Quarter
4Q21 diluted EPS of $0.32 on revenues of $13.0 million up 433% and 156%, respectively Affirms expectations for 1Q22 continued growth and full-year 2022 profitability Conference call begins at 4:30 p.m. Eastern time today BOCA RATON, Fla., Feb. 10, 2022 — Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in highly effective, non-invasive, […]
Sensus Healthcare Prepares Organization for Long-term Growth with Three Promotions
Michael J. Sardano named President, Christopher Machuzak and Jeffrey Starling named Regional Vice Presidents of Sales BOCA RATON, Fla, Jan. 31, 2022 — Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in highly effective, non-invasive treatments for both oncological and non-oncological conditions, announces the following promotions, all effective immediately: Vice President and General […]
Sensus Healthcare to Host Fourth Quarter 2021 Financial Results and Business Update Conference Call on February 10, 2022
BOCA RATON, Fla, Jan. 26, 2022 — Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in highly effective, non-invasive treatments for both oncological and non-oncological conditions, announces that management will hold a conference call on Thursday, February 10, 2022 at 4:30 p.m. Eastern time to discuss the financial results for the fourth quarter […]
Sensus Healthcare to Present at the H.C. Wainwright BioConnect Virtual Conference
Company Management Available for 1×1 Meetings Concurrent with the 40th Annual J.P. Morgan Healthcare Conference January 10-14 BOCA RATON, Fla. , Jan. 06, 2022 — Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in highly effective, non-invasive, minimally-invasive and cost-effective treatments for oncological and non-oncological conditions, announces that Joe Sardano, chairman and chief […]
